Clinical Trials Browser

Phase 2 × Esophageal Neoplasms × romidepsin × Clear all

NCT00098527 2013-07-02

FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer

Phase 2 Terminated

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms